Artiva Biotherapeutics (ARTV) Selling, General & Administrative (2023 - 2026)
Artiva Biotherapeutics' Selling, General & Administrative came in at $4.97 million for Q2 2026, up 0.3% from $4.95 million a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Artiva Biotherapeutics reported Selling, General & Administrative of $20.29 million, up 2.3% year-over-year; for FY2025, it came in at $20.27 million, up 17.8% from FY2024.
- Going back by year, Selling, General & Administrative was $17.21 million in FY2024 (+23.7%) and $13.91 million in FY2023.
- The five-year range for quarterly Selling, General & Administrative is $2.78 million (Q3 2023) to $5.26 million (Q3 2025).
- Year-over-year, Selling, General & Administrative increased in six of the last eight quarters, with growth averaging 26.2%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2024 (growth of 73.1%), and the weakest in Q2 2024 (a decline of 5.0%).
- Business Quant data shows ARTV's Selling, General & Administrative at $5.12 million (Q1 2026), $4.94 million (Q4 2025) and $5.26 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Artiva Biotherapeutics | 269.19 Mn | 269.19 Mn | - | 4.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.97 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 5.26 Mn |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 3.86 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 2.78 Mn |
| Jun 30, 2023 | 4.06 Mn |
API Access
Artiva Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();